23-Feb-2026
Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Sell from Jefferies
TipRanks (Tue, 24-Feb 4:25 AM ET)
UBS Reaffirms Their Sell Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
TipRanks (Tue, 24-Feb 4:25 AM ET)
Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Sell from J.P. Morgan
TipRanks (Tue, 24-Feb 3:35 AM ET)
Barclays Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
TipRanks (Tue, 24-Feb 3:25 AM ET)
Goldman Sachs Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
TipRanks (Tue, 24-Feb 3:25 AM ET)
Seeking Alpha News (Tue, 24-Feb 1:23 AM ET)
Here are the major earnings before the open Tuesday
Seeking Alpha News (Mon, 23-Feb 6:00 PM ET)
Fresenius Medical Care Q4 2025 Earnings Preview
Seeking Alpha News (Mon, 23-Feb 10:09 AM ET)
PRNewswire (Fri, 9-Jan 7:00 AM ET)
PRNewswire (Wed, 10-Dec 8:00 AM ET)
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
Fresenius Medical Care Ag American Depositary Shares (Each Representing 1/2 Of An Ordinary Share) trades on the NYSE stock market under the symbol FMS.
As of February 23, 2026, FMS stock price climbed to $24.59 with 556,664 million shares trading.
FMS has a beta of 0.38, meaning it tends to be less sensitive to market movements. FMS has a correlation of 0.06 to the broad based SPY ETF.
FMS has a market cap of $14.43 billion. This is considered a Large Cap stock.
Last quarter Fresenius Medical Care Ag American Depositary Shares (Each Representing 1/2 Of An Ordinary Share) reported $6 billion in Revenue and $.64 earnings per share. This beat revenue expectation by $232 million and exceeded earnings estimates by $.05.
In the last 3 years, FMS traded as high as $30.46 and as low as $16.37.
The top ETF exchange traded funds that FMS belongs to (by Net Assets): APIE, AVDE, CVAR, TIIV, AVSD.
FMS has underperformed the market in the last year with a return of +10.6%, while SPY returned +13.0%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in FMS shares. However, FMS has outperformed the market in the last 3 month and 2 week periods, returning +8.9% and +2.1%, while SPY returned +4.9% and -1.2%, respectively. This indicates FMS has been having a stronger performance recently.
FMS support price is $24.04 and resistance is $24.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FMS shares will trade within this expected range on the day.